您的位置: 首页 > 农业专利 > 详情页

METHOD AND COMPOSITION FOR TREATING HEPATOCELLULAR CARCINOMA WITHOUT VIRAL INFECTION BY CONTROLLING THE LIPID HOMEOSTASIS
专利权人:
NATIONAL HEALTH RESEARCH INSTITUTES
发明人:
Shih-Feng TSAI,Yung-Feng LIN,Ning HSU
申请号:
US16753670
公开号:
US20200239588A1
申请日:
2018.10.05
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to a method and a pharmaceutical composition for treating an HCC negative for HBV/HCV, comprising administering a subject in need thereof an therapeutically effective amount of an inhibitory agent to control the genetic alteration of lipid homeostasis associated genes, including CD36 amplification and ABCG4 deletion. According to the present invention, medicines targeting the lipid metabolism pathways are developed to treat HCC patients with CD36 amplification and/or ABCG4 deletion.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充